Aurinia Pharmaceuticals AUPH Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aurinia Pharmaceuticals's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aurinia Pharmaceuticals's accounts payable?
- Aurinia Pharmaceuticals (AUPH) reported accounts payable of $2.66M in Q1 2026.
- How has Aurinia Pharmaceuticals's accounts payable changed year-over-year?
- Aurinia Pharmaceuticals's accounts payable decreased by 36.9% year-over-year, from $4.22M to $2.66M.
- What is the long-term trend for Aurinia Pharmaceuticals's accounts payable?
- Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's accounts payable has grown at a 4.7% compound annual growth rate (CAGR), from $2.64M to $3.31M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.